Metabolic and hemodynamic effects of sodium‐dependent glucose cotransporter 2 inhibitors on cardio‐renal protection in the treatment of patients with type 2 diabetes mellitus

por Kashiwagi, Atsunori, Maegawa, Hiroshi
Publicado 2017

Lipotoxicity, Nutrient-Sensing Signals, and Autophagy in Diabetic Nephropathy

por Kume, Shinji, Maegawa, Hiroshi
Publicado 2020

Role of O‐linked N‐acetylglucosamine in the homeostasis of metabolic organs, and its potential links with diabetes and its complications

por Morino, Katsutaro, Maegawa, Hiroshi
Publicado 2020

A new era of diabetic kidney disease treatment with sodium–glucose cotransporter‐2 inhibitors

por Kume, Shinji, Maegawa, Hiroshi
Publicado 2022

Sodium–glucose cotransporter 2 inhibitors represent a paradigm shift in the prevention of heart failure in type 2 diabetes patients

por Kashiwagi, Atsunori, Araki, Shinchi, Maegawa, Hiroshi
Publicado 2020

Roles of mTOR in Diabetic Kidney Disease

por Yasuda-Yamahara, Mako, Kume, Shinji, Maegawa, Hiroshi
Publicado 2021

Role of Nutrient-Sensing Signals in the Pathogenesis of Diabetic Nephropathy

por Kume, Shinji, Koya, Daisuke, Uzu, Takashi, Maegawa, Hiroshi
Publicado 2014

Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study

por Nakamura, Ichiro, Maegawa, Hiroshi, Tobe, Kazuyuki, Uno, Satoshi
Publicado 2019

Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM

por Nakamura, Ichiro, Maegawa, Hiroshi, Tobe, Kazuyuki, Uno, Satoshi
Publicado 2021

Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM

por Nakamura, Ichiro, Maegawa, Hiroshi, Tobe, Kazuyuki, Uno, Satoshi
Publicado 2021

Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM

por Nakamura, Ichiro, Maegawa, Hiroshi, Tobe, Kazuyuki, Uno, Satoshi
Publicado 2021

Correction to: Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study

por Nakamura, Ichiro, Maegawa, Hiroshi, Tobe, Kazuyuki, Uno, Satoshi
Publicado 2021

Impact of body mass index on the efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A subgroup analysis of 3‐month interim results from the Sp...

por Tobe, Kazuyuki, Maegawa, Hiroshi, Tabuchi, Hiromi, Nakamura, Ichiro, Uno, Satoshi
Publicado 2019

Clinical inertia in patients with type 2 diabetes treated with oral antidiabetic drugs: Results from a Japanese cohort study (JDDM53)

por Maegawa, Hiroshi, Ishigaki, Yasushi, Langer, Jakob, Saotome‐Nakamura, Ai, Andersen, Marc
Publicado 2020

The Role of Autophagy in the Pathogenesis of Diabetic Nephropathy

por Yamahara, Kosuke, Yasuda, Mako, Kume, Shinji, Koya, Daisuke, Maegawa, Hiroshi, Uzu, Takashi
Publicado 2013

Combination of disease duration‐to‐age at diagnosis and hemoglobin A1c‐to‐serum C‐peptide reactivity ratios predicts patient response to glucose‐lowering medication in type 2 diabe...

por Kanatsuka, Azuma, Sato, Yasunori, Higashi, Yoichiro, Goto, Yoshimasa, Kawai, Koichi, Maegawa, Hiroshi
Publicado 2021

Autophagy as a Therapeutic Target in Diabetic Nephropathy

por Tanaka, Yuki, Kume, Shinji, Kitada, Munehiro, Kanasaki, Keizo, Uzu, Takashi, Maegawa, Hiroshi, Koya, Daisuke
Publicado 2012

Gene Therapy for Neuropathic Pain by Silencing of TNF-α Expression with Lentiviral Vectors Targeting the Dorsal Root Ganglion in Mice

por Ogawa, Nobuhiro, Kawai, Hiromichi, Terashima, Tomoya, Kojima, Hideto, Oka, Kazuhiro, Chan, Lawrence, Maegawa, Hiroshi
Publicado 2014

Amla Enhances Mitochondrial Spare Respiratory Capacity by Increasing Mitochondrial Biogenesis and Antioxidant Systems in a Murine Skeletal Muscle Cell Line

por Yamamoto, Hirotaka, Morino, Katsutaro, Mengistu, Lemecha, Ishibashi, Taishi, Kiriyama, Kohei, Ikami, Takao, Maegawa, Hiroshi
Publicado 2016

Glucagon-Like Peptide-1 Receptor Agonist Utilization in Type 2 Diabetes in Japan: A Retrospective Database Analysis (JDDM 57)

por Ishigaki, Yasushi, Strizek, Alena, Aranishi, Toshihiko, Arai, Nobuhiro, Imaoka, Takeshi, Cai, Zhihong, Maegawa, Hiroshi
Publicado 2020